Similar associations have been reported in gastric, colorectal, hepatocellular, and breast cancers, where CREPT expression is often upregulated and linked to poor prognosis based on Kaplan–Meier analyses [18,30,31]. The gene discussed is RPRD1B; the disease is breast cancer.